Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hall, Kirsten Sundby
SSGXX, NCT00790244 / 2007-001152-39: A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall	Recruiting	2	188	Europe	doxorubicin , ifosfamide, Doxorubicin, Holoxan, doxorubicin, ifosfamide	Oslo University Hospital, Scandinavian Sarcoma Group	Soft Tissue Sarcoma, Non Metastatic Disease	10/12	10/22